Compare KZIA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | TOMZ |
|---|---|---|
| Founded | 1994 | 1979 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 17.5M |
| IPO Year | 1999 | N/A |
| Metric | KZIA | TOMZ |
|---|---|---|
| Price | $13.05 | $0.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $16.00 | $3.50 |
| AVG Volume (30 Days) | ★ 1.9M | 19.5K |
| Earning Date | 12-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,199,108.00 | ★ $5,688,341.00 |
| Revenue This Year | N/A | $18.31 |
| Revenue Next Year | N/A | $103.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.86 | $0.63 |
| 52 Week High | $25.40 | $1.50 |
| Indicator | KZIA | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 43.84 |
| Support Level | $7.68 | $0.76 |
| Resistance Level | $11.13 | $0.85 |
| Average True Range (ATR) | 2.06 | 0.04 |
| MACD | 0.52 | 0.00 |
| Stochastic Oscillator | 69.83 | 59.46 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.